drug · gene
patient view →obecabtagene autoleucel
Phase 3updated 2mo agoby $AUTL Autolus Therapeutics plc🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with an approval for b-cell acute lymphoblastic leukemia and 3 investigational indications.
targets
B-lymphocyte antigen CD19
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that